If you have experienced anaphylaxis or angioedema attributed to Trulicity, the medication should not be restarted
Comparative outcomes of empagliflozin to Dapagliflozin in patients with heart failure
Glp1r / mice lose significantly more weight, exhibit significantly increased disease activity scores and greater colon damage than wild-type controls in response to DSS-induced colitis (Yusta et al., 2015)
Both groups deserve providers who understand their context
Reddys, Biocon, Cipla, and Sun Pharma, developing GLP-1 generics (Reuters, 2024), face: Bioequivalence Hurdles: Peptides like semaglutide require advanced analytics for CDSCO compliance (Biosimilar Guidelines, 2016), with impurities risking immunogenicity (ResearchGate, 2023)